Skip to main content
Top
Published in: European Radiology 12/2006

01-12-2006 | Breast

The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls

Authors: R. Kaas, R. Kroger, J. L. Peterse, A. A. M. Hart, S. H. Muller

Published in: European Radiology | Issue 12/2006

Login to get access

Abstract

Breast cancers in BRCA1 gene mutation carriers often have specific histologic features: grade III tumors with pushing margins. Our purpose was to compare the mammographic and histologic features of breast cancers in carriers with those in age-matched sporadic controls. The features of breast cancers in 27 BRCA1 carriers found during annual surveillance were compared to those in 107 age-matched sporadic controls. The carriers had no (classic) spiculated mammographic lesions, a high percentage of well-defined masses and hardly any masses with microcalcifications, whereas the controls had significantly fewer well-defined ones and only in 27% spiculated lesions on the mammogram. The well-defined mammographic tumors correlated in 83% of the carriers and in 70% of the controls with histologic circumscribed tumor margins. Spiculated mammographic lesions in the controls were in 90% grade I or II tumors. DCIS with or without infiltration was seen in 22% of the carriers and in 45% of the controls. In conclusion, breast cancers diagnosed in BRCA1 carriers do not have classic malignant mammographic features. A minority of the young sporadic controls show the classic malignant lesion on the mammogram. Both carriers and controls generally show a good correlation between their mammographic- and histologic tumor pattern.
Literature
1.
go back to reference Breast Cancer Linkage Consortium (1997) Pathology of familial breast cancer: differences between breast cancer in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349:1505–1510CrossRef Breast Cancer Linkage Consortium (1997) Pathology of familial breast cancer: differences between breast cancer in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349:1505–1510CrossRef
2.
go back to reference Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, Vijver MJ van der et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998 90:1138–1145CrossRef Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, Vijver MJ van der et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 1998 90:1138–1145CrossRef
3.
go back to reference Armes JE, Egan AJM, Southey MC, Dite GS, McCredie MRE, Giles GG et al (1998) The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations. Cancer 83:2335–2345PubMedCrossRef Armes JE, Egan AJM, Southey MC, Dite GS, McCredie MRE, Giles GG et al (1998) The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations. Cancer 83:2335–2345PubMedCrossRef
4.
go back to reference Lidereau R, Eisinger F, Champeme M-H, Nogues C, Bieche I, Birnbaum D et al (2000) Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer research 60:1206–1210PubMed Lidereau R, Eisinger F, Champeme M-H, Nogues C, Bieche I, Birnbaum D et al (2000) Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer. Cancer research 60:1206–1210PubMed
5.
go back to reference Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S et al (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12:888–894PubMed Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S et al (1994) Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 12:888–894PubMed
6.
go back to reference Sidoni A, Cavaliere A, Bellezza G, Scheibel M, Bucciarelli E (2003) Breast cancer in young women: clinicopathological features and biological specificity. Breast 12:247–250PubMedCrossRef Sidoni A, Cavaliere A, Bellezza G, Scheibel M, Bucciarelli E (2003) Breast cancer in young women: clinicopathological features and biological specificity. Breast 12:247–250PubMedCrossRef
7.
go back to reference Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot J-C, Jager JJ et al (2003) Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer 39:932–944PubMedCrossRef Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot J-C, Jager JJ et al (2003) Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? Eur J Cancer 39:932–944PubMedCrossRef
8.
go back to reference Lakhani SR, Vijver MJ vd, Jacquemier J, Anderson TJ, Osin PP, McGuffog L et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20:2310–2318PubMedCrossRef Lakhani SR, Vijver MJ vd, Jacquemier J, Anderson TJ, Osin PP, McGuffog L et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20:2310–2318PubMedCrossRef
9.
go back to reference Gils CH van, Otten JDM, Verbeek ALM, Hendriks JHCL (1995) Short communication: breast parenchymal patterns and their changes with age. Br J Radiol 68:1133–1135PubMedCrossRef Gils CH van, Otten JDM, Verbeek ALM, Hendriks JHCL (1995) Short communication: breast parenchymal patterns and their changes with age. Br J Radiol 68:1133–1135PubMedCrossRef
10.
go back to reference Huo Z, Giger Ml, Olopade OI, Wolverton DE, Weber BL, Metz CE et al (2002) Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. Radiology 225:519–526PubMed Huo Z, Giger Ml, Olopade OI, Wolverton DE, Weber BL, Metz CE et al (2002) Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. Radiology 225:519–526PubMed
11.
go back to reference Kaas R, Kroger R, Hendriks JHCL, Besnard APE, Koops W, Pameijer FA et al (2004) The significance of circumscribed malignant mammographic masses in the surveillance of BRCA1/2 gene mutation carriers. Eur Radiol 14:1647–1653PubMedCrossRef Kaas R, Kroger R, Hendriks JHCL, Besnard APE, Koops W, Pameijer FA et al (2004) The significance of circumscribed malignant mammographic masses in the surveillance of BRCA1/2 gene mutation carriers. Eur Radiol 14:1647–1653PubMedCrossRef
12.
go back to reference Malone KE, Daling JR, Neal C, Suter NM, O’Brien C, Cushing-Haugen K et al (2000) Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 88:1393–1402PubMedCrossRef Malone KE, Daling JR, Neal C, Suter NM, O’Brien C, Cushing-Haugen K et al (2000) Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 88:1393–1402PubMedCrossRef
13.
go back to reference Papelard H, Bock GH de, Eijk R van, Vliet Vlieland TPM, Cornelisse CJ, Devilee P, Tollenaar RAEM (2000) Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients. BrJCancer 83:719–724PubMedCrossRef Papelard H, Bock GH de, Eijk R van, Vliet Vlieland TPM, Cornelisse CJ, Devilee P, Tollenaar RAEM (2000) Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients. BrJCancer 83:719–724PubMedCrossRef
14.
go back to reference Tabar L, Dean PB. Teaching atlas of mammography. Second revised edition (1985) Georg Thieme Verlag Stuttgart, New York Tabar L, Dean PB. Teaching atlas of mammography. Second revised edition (1985) Georg Thieme Verlag Stuttgart, New York
15.
go back to reference Mammography 4th edition (2003). In: ACR Breast imaging reporting and data system, Breast imaging atlas. Reston VA American College of Radiology Mammography 4th edition (2003). In: ACR Breast imaging reporting and data system, Breast imaging atlas. Reston VA American College of Radiology
16.
go back to reference Kopans DB (1998) Breast imaging, second edition Lippincott-Raven publishers, Philadelphia Kopans DB (1998) Breast imaging, second edition Lippincott-Raven publishers, Philadelphia
17.
go back to reference Tabar L, Tot T, Dean PB (2005) Breast Cancer. The art and science of early detection with mammography Georg Thieme Verlag Stuttgart, New York Tabar L, Tot T, Dean PB (2005) Breast Cancer. The art and science of early detection with mammography Georg Thieme Verlag Stuttgart, New York
18.
go back to reference Hamilton LJ, Evans AJ, Wilson ARM, Scott N, Cornford EJ, Pinder SE et al (2004). Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma. Clinical Radiology 59:895–902PubMedCrossRef Hamilton LJ, Evans AJ, Wilson ARM, Scott N, Cornford EJ, Pinder SE et al (2004). Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma. Clinical Radiology 59:895–902PubMedCrossRef
19.
go back to reference Tilanus-Linthorst M, Verhoog L, Obdeijn IM, Bartels K, Menke-Pluymers M, Eggermont A et al (2002) A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer 102:91–95PubMedCrossRef Tilanus-Linthorst M, Verhoog L, Obdeijn IM, Bartels K, Menke-Pluymers M, Eggermont A et al (2002) A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer 102:91–95PubMedCrossRef
20.
go back to reference Zonderland HM, Pope Jr ThL, Nieborg AJ (2004) The positive predictive value of the breast imaging reporting and data system (BI-RADS) as a method of quality assessment in breast imaging in a hospital population. Eur Radiol 14:1743–1750PubMedCrossRef Zonderland HM, Pope Jr ThL, Nieborg AJ (2004) The positive predictive value of the breast imaging reporting and data system (BI-RADS) as a method of quality assessment in breast imaging in a hospital population. Eur Radiol 14:1743–1750PubMedCrossRef
Metadata
Title
The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls
Authors
R. Kaas
R. Kroger
J. L. Peterse
A. A. M. Hart
S. H. Muller
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
European Radiology / Issue 12/2006
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-006-0385-0

Other articles of this Issue 12/2006

European Radiology 12/2006 Go to the issue